Mouse potency assay for Western equine encephalomyelitis vaccines

Area of Science:

• Veterinary Virology
• Immunology
• Vaccine Development

Background:

• Western equine encephalomyelitis (WEE) is a significant zoonotic disease.
• Potency assays are crucial for ensuring vaccine efficacy and safety.
• Traditional WEE vaccine assays often use guinea pigs or hamsters.

Purpose of the Study:

• To develop and validate a novel potency assay for Western equine encephalomyelitis vaccine.
• To evaluate the use of mice as an alternative animal model for vaccine potency testing.
• To compare the performance of the mouse-based assay with existing methods.

Main Methods:

• Development of an intracerebral challenge model in mice using virulent WEE virus.
• Immunization of mice with serial dilutions of WEE vaccine.
• Mathematical determination of the 50% protective dose (ED50) in mice.
• Comparative analysis of ED50 values obtained from mouse and guinea pig immunization.

Main Results:

• A reproducible mouse model was established for WEE vaccine potency assessment.
• The ED50 values derived from mouse immunization were consistent across different vaccine dilutions.
• No significant differences were observed in vaccine rankings when comparing mouse and guinea pig assay results.

Conclusions:

• Mice serve as a suitable and effective animal model for WEE vaccine potency assays.
• The developed mouse-based assay provides a reliable alternative to traditional methods.
• This advancement can potentially streamline vaccine quality control and reduce reliance on other animal models.